BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

706 related articles for article (PubMed ID: 11226692)

  • 1. Nociceptin/orphanin FQ regulates neuroendocrine function of the limbic-hypothalamic-pituitary-adrenal axis.
    Devine DP; Watson SJ; Akil H
    Neuroscience; 2001; 102(3):541-53. PubMed ID: 11226692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nociceptin receptor antagonist [Nphe1,Arg14,Lys15]nociceptin/orphanin FQ-NH2 blocks the stimulatory effects of nociceptin/orphanin FQ on the HPA axis in rats.
    Leggett JD; Harbuz MS; Jessop DS; Fulford AJ
    Neuroscience; 2006 Sep; 141(4):2051-7. PubMed ID: 16784820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nociceptin/orphanin FQ antagonist UFP-101 differentially modulates the glucocorticoid response to restraint stress in rats during the peak and nadir phases of the hypothalamo-pituitary-adrenal axis circadian rhythm.
    Leggett JD; Jessop DS; Fulford AJ
    Neuroscience; 2007 Jul; 147(3):757-64. PubMed ID: 17574767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of the bed nucleus of stria terminalis and of the amygdala in N/OFQ-mediated anxiety and HPA axis activation.
    Green MK; Barbieri EV; Brown BD; Chen KW; Devine DP
    Neuropeptides; 2007 Dec; 41(6):399-410. PubMed ID: 17980908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nociceptin/orphanin FQ increases anxiety-related behavior and circulating levels of corticosterone during neophobic tests of anxiety.
    Fernandez F; Misilmeri MA; Felger JC; Devine DP
    Neuropsychopharmacology; 2004 Jan; 29(1):59-71. PubMed ID: 14532912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of nociceptin/orphanin FQ and NOP receptors in the response to acute and repeated restraint stress in rats.
    Delaney G; Dawe KL; Hogan R; Hunjan T; Roper J; Hazell G; Lolait SJ; Fulford AJ
    J Neuroendocrinol; 2012 Dec; 24(12):1527-41. PubMed ID: 22835008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central corticotropin-releasing hormone receptors modulate hypothalamic-pituitary-adrenocortical and sympathoadrenal activity during stress.
    Jezova D; Ochedalski T; Glickman M; Kiss A; Aguilera G
    Neuroscience; 1999; 94(3):797-802. PubMed ID: 10579570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of orphanin FQ/nociceptin (OFQ/N) system with immune system factors and hypothalamic-pituitary-adrenal (HPA) axis.
    Bodera P; Stankiewicz W; Kocik J
    Pharmacol Rep; 2014 Apr; 66(2):288-91. PubMed ID: 24911083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orphanin FQ (nociceptin) modulates responses of trigeminal neurons evoked by excitatory amino acids and somatosensory stimuli, and blocks the substance P-induced facilitation of N-methyl-D-aspartate-evoked responses.
    Wang XM; Zhang KM; Long LO; Mokha SS
    Neuroscience; 1999; 93(2):703-12. PubMed ID: 10465454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous nociceptin / orphanin FQ system involvement in hypothalamic-pituitary-adrenal axis responses: relevance to models of inflammation.
    Leggett JD; Dawe KL; Jessop DS; Fulford AJ
    J Neuroendocrinol; 2009 Nov; 21(11):888-97. PubMed ID: 19732291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nociceptin/orphanin FQ content is decreased in forebrain neurones during acute stress.
    Devine DP; Hoversten MT; Ueda Y; Akil H
    J Neuroendocrinol; 2003 Jan; 15(1):69-74. PubMed ID: 12535171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-Terminal glycine is crucial for hyperalgesic activity of nociceptin/orphanin FQ-(1-6).
    Kotlińska J; Suder P; Sciubisz A; Łegowska A; Eilmes J; Rolka K; Silberring J
    Eur J Pharmacol; 2001 May; 419(1):33-7. PubMed ID: 11348627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nociceptin/orphanin FQ microinjected into hippocampus impairs spatial learning in rats.
    Sandin J; Georgieva J; Schött PA; Ogren SO; Terenius L
    Eur J Neurosci; 1997 Jan; 9(1):194-7. PubMed ID: 9042583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracerebroventricular administration of corticotrophin-releasing hormone receptor antagonists produces different effects on hypothalamic pituitary adrenal responses to novel restraint depending on the stress history of the animal.
    Vining C; Iyer V; Bhatnagar S
    J Neuroendocrinol; 2007 Mar; 19(3):198-207. PubMed ID: 17280593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroimmunological effects of exposure to methylmercury forms in the Sprague-Dawley rats. Activation of the hypothalamic-pituitary-adrenal axis and lymphocyte responsiveness.
    Ortega HG; Lopez M; Takaki A; Huang QH; Arimura A; Salvaggio JE
    Toxicol Ind Health; 1997; 13(1):57-66. PubMed ID: 9098950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between oestrogen and oxytocin on hypothalamic-pituitary-adrenal axis activity.
    Ochedalski T; Subburaju S; Wynn PC; Aguilera G
    J Neuroendocrinol; 2007 Mar; 19(3):189-97. PubMed ID: 17280592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nociceptin/orphanin FQ receptor system blockade as an innovative strategy for increasing resilience to stress.
    Gavioli EC; Holanda VAD; Calo G; Ruzza C
    Peptides; 2021 Jul; 141():170548. PubMed ID: 33862163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoids are involved in the long-term effects of a single immobilization stress on the hypothalamic-pituitary-adrenal axis.
    Dal-Zotto S; Martí O; Armario A
    Psychoneuroendocrinology; 2003 Nov; 28(8):992-1009. PubMed ID: 14529704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imidazoline2 (I2) receptor- and alpha2-adrenoceptor-mediated modulation of hypothalamic-pituitary-adrenal axis activity in control and acute restraint stressed rats.
    Finn DP; Hudson AL; Kinoshita H; Coventry TL; Jessop DS; Nutt DJ; Harbuz MS
    J Psychopharmacol; 2004 Mar; 18(1):47-53. PubMed ID: 15107184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nociceptin/orphanin FQ and related peptides reduce the increase in plasma corticosterone elicited in mice by an intracerebroventricular injection.
    Le Cudennec C; Naudin B; Do Rego JC; Costentin J
    Life Sci; 2002 Nov; 72(2):163-71. PubMed ID: 12417250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.